The scientific perspective behind cell pattern formation involves observing both the commonly seen principles behind similar cell-patterns seen in nature and the visible events of self-organization.

Image Credit: naramit/Shutterstock.com

In developmental cell biology, the phrase pattern formation is used in reference to the propagation of complex organizations of cell fates in time and space. Pattern formation is mainly controlled via genes, such as homeobox type genes.

The vital role of genetics in pattern formation is a facet of morphogenesis: the creation of diversified anatomies from similar genes, which are now being examined in studies covering evolutionary developmental biology. The mechanisms that are involved can be observed in the anterior-posterior patterning of Drosophila melanogaster embryos, which were one of the first organisms to have had their morphogenesis studied.

Mutations in the maize-defective kernel 1 (dek1) gene are blocked during embryogenesis, and the endosperm is chalky and lacks an aleurone layer. It has previously been seen in scientific studies that intermediate alleles can result in embryos that do not have a shoot axis, whilst the presence of weak alleles tends to result in endosperms with mosaic aleurone, as well as deformed plants that have epidermal cells that resemble bulliform cells (which is a specialized type of epidermal cell).

This, therefore, shows that the dek1 gene functions in cell fate specification, embryonic pattern formation, and generalized pattern formation in the leaf epidermis, as well as cell fate specificity in the endosperm.

Thus, the products of these genes appear to have significant control over the different cellular development processes, of course depending on the cellular context. The resulting phenotype of the weakened dek1-Dooner allele was found to be strikingly similar to the phenotype of the crinkly4 mutant. Double mutants with genetic changes being found between the dek1 and cr4 genes showed aspects of epistasis, synergy, and additivity therefore suggesting that the final genetic products could function in several overlapping processes of development.

Gene analysis of the development of the maize aleurone was conducted in a scientific study, in which cell lineage was observed by synchronously marking its cells with a C1 marker for anthocyanin pigmentation within the aleurone, and with a wx1 marker for amylose synthesis inside the starchy endosperm.

The starchy endosperm and aleurone share a similar lineage in the entirety of its development, which indicates that certain positional cues could be observed to specify the fate of the aleurone. Mutations within in dek1 gene have also been found to block any aleurone formation from early stages, thus causing any peripheral endosperm cells to form and grow as starchy endosperm.

The growth of plants, like all other multicellular eukaryotic organisms, is dependent upon the suitable specification of any distinctive types of cells. The development of plant cells that possess hairs within the epidermis has been utilized previously as an accessible model to study specific cell-fate specification.

For example, in the Arabidopsis plant, the root hair distribution inside the roots and trichomes on the shoots have been shown to differ greatly. Root-hair cells have been observed to develop in a pattern, dependent upon position, on top of the intercellular spaces that can be found in between any underlying cortical cells.

Conversely, the final spacing of any trichomes on the top surfaces of Arabidopsis stems, and leaves are no way dependent upon the positioning of any underlying cells. In reality, these trichomes are distributed relatively regularly inside the epidermal cell fields, with their final spacing likely being due to the inhibitory interactions between biomolecular precursors during plant development.

Recent studies on this topic have also suggested that, although the vastly different distribution of the hair cells inside the shoots and roots, a similar biomolecular mechanism is responsible for the initial patterning inside both of these types of cells.

View post:
Pattern Formation and Cell Fate in Development - News-Medical.net

Cell Biology

Scientists to Explore New Frontiers in Parkinsons Disease Research with $7.2M Grant – Newswise

September 18, 2020 medical

Newswise In August, a team of researchers at the University of California San Diego published groundbreaking back-to-back studies describing unprecedented details of a protein linked to genetically inherited Parkinsons disease. The researchers produced the first visualizations of leucine-rich repeat kinase 2, or LRRK2, as seen within its natural environment inside the cell, as well as the first high-resolution blueprint of the protein.

The Aligning Science Across Parkinsons (ASAP) initiative has announced support for the next phase of the research as the scientists focus on understanding the basic mechanisms underlying Parkinsons, a neurodegenerative disorder affecting millions. ASAPs goal is to support research that will inform a path to a cure for Parkinsons. The three-year, $7.2 million grant will fund research across three UC San Diego laboratories and two others based in Germany. The Michael J. Fox Foundation for Parkinsons Research is the implementation partner for ASAP and issuer of the grant, which contributes to the Campaign for UC San Diego.

This grant from ASAP will further advance UC San Diegos efforts at unraveling the core debilitating effects of Parkinsons disease, which impacts the lives of so many individuals and families around the world, said UC San Diego Chancellor Pradeep K. Khosla. This support will keep our researchers at the forefront of the science and technology needed to fully understand the mechanisms underlying the disease.

Since LRRK2 was discovered and linked to Parkinsons in the early 2000s, scientists have vigorously pursued clues about its form and function. The new funding expands efforts at UC San Diego using leading-edge cryo-electron microscopy (cryo-EM) to produce previously unseen views of biologically important cells and molecules.

The goal of this project is to understand the basic cell biology and structure of this really fundamentally important LRRK2 molecule, said Samara Reck-Peterson, the lead principal investigator of the project, a professor at UC San Diego School of Medicine and Division of Biological Sciences and a Howard Hughes Medical Institute investigator. If we can find out why LRRK2when it doesnt workcauses Parkinsons disease, thats really the ultimate goal. When you are thinking about designing a drug, you really need to understand all the details of the parts in order to engineer therapeutics.

Project co-principal investigator Andres Leschziner and his colleagues have used the growing cryo-EM facility at UC San Diego to produce atomic-level visualizations of LRRK2 in the most detailed images of the protein to date. Leschziner plans to use cryo-EM to develop a full blueprint of LRRK2 in normal and mutant states.

LRRK2 is a complicated molecule with a lot of moving parts, and its dynamic behavior is very likely to play a role in both its normal function and Parkinsons pathology. Understanding how the structure of LRRK2 changes in different states and with different disease mutations will be key to developing treatments. The equipment and expertise in cryo-EM here at UC San Diego put us in a great position to visualize all of this, said Leschziner, a professor at UC San Diego School of Medicine and Division of Biological Sciences.

Biological Sciences Assistant Professor and project co-principal investigator Elizabeth Villa uses a related technology called cryo-electron tomography (cryo-ET) to visualize LRRK2 in its natural living environment within the cell. In combination with other techniques, Villas lab will continue to examine mutant forms of LRRK2 as it interacts with a network of components in the cell in health and disease.

We are just starting to understand the roles of LRRK2 in various cellular processes, said Villa. Using high-end technologies, we are, for the first time, able to directly see LRRK2 as it performs these roles, as well as what happens when mutations affect LRRK2s function. By opening windows into LRRK2 in cells, we can answer longstanding questions and generate new ones. It is humbling and empowering to know that our basic research can benefit people who suffer from this debilitating disease.

Reck-Petersons expertise focuses on roadways of tracks called microtubules that move important cargoes around the cell. Previous evidence suggests that LRRK2 plays a role in how these components move along these cellular tracks. Her lab will be investigating cargo movements when LRRK2 is normal and in diseased states, and whether interactions with microtubules are linked to Parkinsons.

The LRRK2 project and the new funding are the latest achievements underscoring the universitys rising cryo-EM facility. Cryo-EM, in which scientists freeze molecules in a thin layer of ice to determine their structure at high resolution, has exploded in scientific prominence over the last decade as the technology provides unique insights into a range of biological phenomena.

This project will build upon the universitys investments in cryo-EM technology and deliver new insights into Parkinsons disease that promise to lead to new treatments, said Division of Biological Sciences Dean Kit Pogliano. Im grateful to ASAP for recognizing that this all-star team of scientists is well-equipped to make transformational discoveries that will provide new insights into the biology of this devastating disease.

Co-principal investigator Stefan Knapp, a professor at Goethe University in Frankfurt, Germany, will be engineering samples of LRRK2 that the team members can use to help decode its full structure, and will also design probes to locate LRRK2 inside cells for both live-cell imaging and cryo-ET. The fifth team member, Florian Stengal of Konstanz University in Germany, brings expertise in mass spectrometry, an analytical tool that will help the team develop a complete picture of all of the proteins LRRK2 interacts with in normal and Parkinsons cells.

All five team members are going to be working in their specialties but toward our common goals, and theres going to be a lot of crosstalk among the team, said Reck-Peterson. One of the things that were really excited about is that every member of the team brings a unique strength and weve already shown that we are really good at working together given our track record of collaboration.

The new funding allows the UC San Diego labs to rapidly expand their teams focusing on LRRK2 research. Initial phases of this research were funded by The Michael J. Fox Foundation for Parkinsons Research in an effort spearheaded by UC San Diegos Susan Taylor, a distinguished professor in Chemistry and Biochemistry and Pharmacology and world-renowned expert in protein kinases, one of the largest gene families to which LRRK2 belongs.

UC San Diego has a long and accomplished history in uncovering fundamental secrets about how key proteins function in health and diseases kinases in particular, said David A. Brenner, MD, vice chancellor of health sciences at UC San Diego. In more recent years, weve made it a strategic goal to take those efforts to the next level by first recruiting the nations rising stars in protein structure and function and then providing them access to leading-edge technologies such as cryo-EM. I am thrilled to see the success of this reflected in the incredible work of this team.

Private support, like the grant from Aligning Science Across Parkinsons (ASAP) initiative, contributes to theCampaign for UC San Diegoa university-wide comprehensive fundraising effort concluding in 2022.Alongside UC San Diegos philanthropic partners, the university is continuing its nontraditional path toward revolutionary ideas, unexpected answers, lifesaving discoveries and planet-changing impact.To learn more visit the Campaign for UC San Diego website at campaign.ucsd.edu.

Cell Biology

Technological Advancements to back the Time-resolved Fluorescence Microscope Market – Lake Shore Gazette

September 18, 2020 medical

Time-resolved Fluorescence Microscope Market: Introduction

Increasing demand for the advanced, efficient, and high-resolution diagnostic tools in the medical and life science industry leads to significant demand for the fluorescence microscopy. Time-resolved fluorescence microscope seems to be a promising diagnostic tool and have rapid and fast analysis ability which can be used in several fields of medical applications. Time-resolved fluorescence microscopes have emerged as the choice of the researcher to analyze biologic systems and cell biology researches. Time-resolved fluorescence microscope is an efficient tool for the analysis of the fluorescence properties of the sample. Time-resolved fluorescence microscope is generally used to measure the fluorescence properties of the sample or molecules. Time-resolved fluorescence microscope is widely used to analyze organic compounds medical laboratories and used for drug screening applications. Time-resolved fluorescence microscopes are gaining demand for map interactions between lipids, proteins, DNA, RNA, enzymes

Time-resolved Fluorescence Microscope Market: Drivers and Restraints

Increasing adoption of the advance and new technologies among researcher has led to the tremendous growth of the time-resolved fluorescence microscope market. Increasing life science-based research to diagnose the various disease are creating significant demand for the time-resolved fluorescence microscope. Advancement of the Time-resolved fluorescence microscope leads to significant demand for the devices among researchers and medical industry manufacturers. The growing number of biopharmaceutical research and drug discovery are the major factor expected to boost up the demand for the time-resolved fluorescence microscope market. Growing demand for time-resolved fluorescence microscope in medical areas such as molecular and cellular biology, proteomics, biochemistry boost up the growth of the time-resolved fluorescence microscope market. However, factors such as the high cost of the devices and less profitability are some of the factors negatively impact the growth of the time-resolved fluorescence microscope market.

To remain ahead of your competitors, request for a sample here@

https://www.persistencemarketresearch.com/samples/30639

Time-resolved Fluorescence Microscope Market: Segmentation

Tentatively, the global time-resolved fluorescence microscope market can be segmented on the basis of product type, application, end user, and geography.

Based on product type, the global time-resolved fluorescence microscope market is segmented as:

Based on application, the global Time-resolved Fluorescence Microscope market is segmented as:

Based on end users, the global Time-resolved Fluorescence Microscope market is segmented as:

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/30639

Time-resolved Fluorescence Microscope Market: Overview

Since few years time-resolved fluorescence lifetime spectrometry technique applications are continuously growing in the pharmaceutical and biotechnology industry as well as in a laboratory. Time-resolved fluorescence microscopes are used for different applications such as forensic, drug discovery, biologics research, cell biology and biomolecules based researches and more. Moreover, Time-resolved fluorescence microscopes have substantial demand in the academic and research institutes as a growing number of researches and study on the diverse biologic particles.

Time-resolved Fluorescence Microscope Market: Regional Outlook

North America expected to dominate the global time-resolved fluorescence microscope market as high demand for technologically advanced tools for the research purpose. Europe expected to register second higher market value share in global time-resolved fluorescence microscope market as increasing number medical research, molecular and drug discovery. Asia Pacific market expected to register higher opportunities for time-resolved fluorescence microscope market players as increasing healthcare and research funding for medical researches. China, India, South Korea are the major countries in the Asia Pacific market which grow at a faster pace in the medical science and research industry. Japan is the established market for the time-resolved fluorescence microscope market players as high adoption of new technologies in clinical laboratories.

Time-resolved Fluorescence Microscope Market: Key Players

Examples of some of the key players operating in the global time-resolved fluorescence microscope market are Agilent Technologies, Inc, PicoQuanT GmbH, Carl Zeiss AG, Danaher Corporation, Olympus Corporation, Edinburgh Instruments Ltd., HORIBA Scientific, Aurora Biomed Inc., Thermo Fisher Scientific, Malvern Panalytical Ltd. and other companies.

You Can Request for TOC Here @ https://www.persistencemarketresearch.com/toc/30639

Explore Extensive Coverage of PMR`s

Life Sciences & Transformational HealthLandscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Salessales@persistencemarketresearch.comWebsitehttps://www.persistencemarketresearch.com

Read the original here:
Technological Advancements to back the Time-resolved Fluorescence Microscope Market - Lake Shore Gazette

Cell Biology

MDI Biological Laboratory receives 280,000 to address the problem of tendon injury – News-Medical.net

September 18, 2020 medical

Reviewed by Emily Henderson, B.Sc.Sep 17 2020

Modern medicine has made tremendous strides in replacing organs and hips. But what about those all-important tendons, which enable joint movement by connecting muscle to bone? Tendon injuries, such as those in the knee, elbow, Achilles tendon and rotator cuff (shoulder) exact a huge cost in terms of health care, productivity and quality of life.

Prayag Murawala, Ph.D., a scientist at the MDI Biological Laboratory in Bar Harbor, Maine, has received a grant of 280,000 ($332,000) to address the problem of tendon injury. He is seeking to determine if the same cellular and molecular mechanisms responsible for regenerating tendons during limb regeneration in the axolotl, or Mexican salamander, also come into play during tendon regeneration after injury.

The subject of the study draws on Murawala's previous research on the mechanisms governing tendon regeneration in the axolotl limb. The knowledge gained from the study of tendon regeneration in the axolotl could one day be used to develop drugs and therapies to trigger tendon regeneration in adult humans, who are for the most part incapable of regenerating tissues and organs.

Murawala and colleagues at the MDI Biological Laboratory's Kathryn W. Davis Center for Regenerative Biology and Aging use the axolotl, which is considered nature's champion of regeneration because of its ability to regenerate almost any body part, including limb, heart, brain, eye and spinal cord, to explore why the axolotl is capable of such remarkable feats of regeneration while humans are not.

Very few labs in the world are studying tendon biology, which is surprising given how common, painful and debilitating tendon injuries are, and the fact that existing treatments often fail to fully restore function. This grant is great because it will allow us to apply what we have learned from our studies of limb regeneration in the axolotl to an area of biology that is in urgently in need of greater investigation."

Prayag Murawala, Ph.D., Scientist, MDI Biological Laboratory

In the United States, more than 15 million soft tissue and ligament injuries, which include tendon injuries, are reported every year, with Achilles tendon injuries being one of the most common due to overuse or repetitive use. Though tendon injuries are often associated with athletes, such injuries also occur among sedentary populations and are common among the elderly due to age-related degeneration.

The three-year grant from the Deutsche Forschungsgemeinschaft (DFG), or German Research Foundation, which is financed by German state and federal governments, will support the salary of a doctoral student and consumable laboratory supplies. The student's time will be divided between the MDI Biological Laboratory and Hannover Medical School in Hanover, Germany, where Murawala also holds an appointment.

"We are very grateful to the German Research Foundation," said Hermann Haller, M.D., president of the MDI Biological Laboratory. "Because of our focus on aging, we are especially interested in applications for the elderly, for whom the traditional treatments for age-related tendinopathy, such as surgical stitching, are more challenging due to the deterioration in tissue structure and healing ability that occur as we age."

In his earlier research on limb regeneration in the axolotl, Murawala discovered that cells in a regenerating limb called fibroblasts acquire stem cell-like capabilities that allow them to differentiate -- or transform into -- tendon progenitor cells. Tendon progenitor cells are the main source of the various types of connective tissue that proliferate to form a newly regenerated limb, including tendon tissue.

The grant will allow Murawala to study whether a fibroblast's capability to transform into a tendon progenitor cell occurs only during full limb regeneration, or if it also takes place during injury; and, if the same mechanism is employed to heal a tendon injury as to regenerate a limb, what molecular signals guide the transitions that occur during the regenerative process and why they occur in axolotls and not in humans.

The grant will also allow him to study the role of the extra-cellular matrix (ECM), which is the three-dimensional network surrounding the cell, in the transformation of fibroblasts into tendon progenitor cells. Earlier research has demonstrated that the remodeling of the ECM is critical to tendon regeneration.

Murawala's interest in tendon regeneration represents one facet of his broader quest to understand limb regeneration. But his research also has applications for other types of regeneration, including kidney regeneration, which is a focus of research at the MDI Biological Laboratory. "What we learn about regeneration in one part of the body can be useful for understanding regeneration in other parts of the body," he said.

Marawala, who recently joined the MDI Biological Laboratory, was formerly a postdoctoral fellow in the laboratory of Elly Tanaka, Ph.D., a highly regarded scientist who studies limb and spinal cord regeneration in the axolotl at the Research Institute of Molecular Pathology in Vienna, Austria.

The rest is here:
MDI Biological Laboratory receives 280,000 to address the problem of tendon injury - News-Medical.net

Cell Biology

Global Live Cell Imaging Market: Industry Analysis and Forecast (2018-2026) by Product & Service, Application, End-User and Region. – Kewaskum…

September 18, 2020 medical

Global Live Cell Imaging Marketwas valued at US$ 1.5Bn in 2017 and is expected to reach US$ XX Bn by 2026, at a CAGR of XX% during a forecast period.

Global live cell imaging market is majorly influenced by the growing incidence of chronic diseases and the consistent need for swift diagnostic techniques. Availability of exact and accurate live cell imaging techniques also help in accelerating drug discovery processes and other biotechnology research.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/28816

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Growth in expenditure and funding for the development of advanced cell imaging is further expected to boost the live cell imaging market in the future. It is also observed that collaborations of market players with research and academic institutions to develop and introduce breakthrough products have recently gained pace. Small players are being increasingly acquired by large incumbents for procurement of breakthrough technologies to secure their stronghold in the market.

Fluorescence recovery after photobleaching is the most commonly used technique for live cell imaging. The technique has found rapid adoption in genetic targeting peptides and appropriately offers a determination of spatial proximity at a protein level that is not possible through fluorescence microscopy. Rapid introduction of FRET systems with an insight to offer better cell imaging techniques will so determine the major market trends.

Cell biology segment is leading the application owing to the increasing number of researchers working on molecular interaction networks. Innovations, for instance, filter techniques and advanced illumination devices further enable the procedure. Cell biologists use live cell imaging to understand the fundamental cellular structures and their interaction on the tissue level. Benefits are clarity of structural components and spatial heterogeneity of a cell offered by live cell imaging are expected to further boost the market.

North America dominated by market share in 2017 closely followed by Europe. Substantial investments and funding available for research in this field is the key driver in the North America region. The growing adoption of live cell imaging by research laboratories and academic institutions, particularly in the U.S. is one of the major factors driving market growth in this region.

One of the recent acquisition in the industry was done in March 2017 by Sartorius who agreed to buy Essen Bioscience in a transaction worth US$ 320Mn. Essen was energetic in developing equipment, reagents, and software.

Nikon Corporation Company has strategic partnerships with research groups to gain professional expertise. They have established imaging centers and offer microscopes, automation, software, and support to various institutes, for instance, Harvard Medical School.

The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Live Cell Imaging Market dynamics, structure by identifying and analyzing the market segments and project the global market size.

Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTERs analysis, SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the Global Live Cell Imaging Market.

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/28816

Scope of Global Live Cell Imaging Market

Global Live Cell Imaging Market, by Product & Service

Instruments Consumables Software ServicesGlobal Live Cell Imaging Market, by Application

Cell Biology Stem Cells Developmental Biology Drug DiscoverGlobal Live Cell Imaging Market, by End User

Pharmaceutical & Biotechnology Companies Academic & Research Institutes Contract Research OrganizationsGlobal Live Cell Imaging Market, by Region

North America Europe Asia Pacific Middle East and Africa South AmericaKey players operating in Global Live Cell Imaging Market

Danaher Corporation Carl Zeiss AG Nikon Corporation Olympus Corporation Perkinelmer GE Healthcare Bruker Thermo Fisher Scientific Sartorius AG Biotek Instruments Etaluma Cytosmart Technologies Nanoentek

MAJOR TOC OF THE REPORT

Chapter One: Live Cell Imaging Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Live Cell Imaging Market Competition, by Players

Chapter Four: Global Live Cell Imaging Market Size by Regions

Chapter Five: North America Live Cell Imaging Revenue by Countries

Chapter Six: Europe Live Cell Imaging Revenue by Countries

Chapter Seven: Asia-Pacific Live Cell Imaging Revenue by Countries

Chapter Eight: South America Live Cell Imaging Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Live Cell Imaging by Countries

Chapter Ten: Global Live Cell Imaging Market Segment by Type

Chapter Eleven: Global Live Cell Imaging Market Segment by Application

Chapter Twelve: Global Live Cell Imaging Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Live Cell Imaging Market Report at:https://www.maximizemarketresearch.com/market-report/global-live-cell-imaging-market/28816/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

Cell Biology

Vasso Apostolopoulos among the top 50 professors in higher education – Neos Kosmos

September 18, 2020 medical

The Educator Higher Education received hundreds of nominations for the best education professionals in the higher education sector across the country. Among the fifty most influential education professionals is Greek Australian researcher, Professor Vasso Apostolopoulos, honoured for her significant contributions to the sector over the past 12 months.

The world-renowned, multi-awarded researcher was acclaimed for her extensive expertise in immunology, x-ray crystallography, medicinal chemistry, cellular biology, molecular biology, as well as extensive translational research expertise with development of drugs and vaccines.

One of her significant achievements is the development of the concept of immunotherapy for cancer, which aims to boost specific immune cells and program them to kill cancer cell. This treatment, which is now being used by hundreds of labs around the world, has also been used by Professor Apostolopoulos to develop two worlds first vaccines breast cancer vaccine and ovarian cancer vaccine. In response to the ongoing COVID-19 pandemic, Professor Apostolopoulos and her team in Victoria Universitys Immunology & Translational research are now focusing their efforts on investigating and working on vaccines and drugs to treat the virus.

READ MORE:Trailblazing Greek Australian Dr Vasso Apostolopoulos making strides in COVID-19 research

Some of the awards Professor Apostolopoulos has received include Premiers Award for Medical Research, Young Australian of the Year (Vic), Greek Australian of the Year, and Woman of the Year. She was named as one of the most successful Greeks abroad by the prestigious Times magazine.Her name could not be missing from this list of the best who grabbed the academic spotlight for numerous contributions ranging from championing the latest tech innovations, establishing new standards of best practice in Australian education, demonstrating educational leadership, to coming up with outstanding research and research impact.

More:
Vasso Apostolopoulos among the top 50 professors in higher education - Neos Kosmos

Biochemistry

Scientist takes a closer look at the genome – University of Miami

September 18, 2020 medical

With a $1.82 million grant, computer scientist and bioinformatic researcher Zheng Wang is poised to help researchers see every aspect of the genome in super-resolution 3D.

Breakthrough advances in biomedical technology have come a long way, especially with three-dimensional mapping of the structure of the genome. For years, scientists and researchers have attempted to obtain and analyze the entire 3D structure of an organism's DNA to observe and understand its complex organization and how the genes function and interact.

Now, by combining cutting-edge computer science techniqueswith leading biomedical technologies, computer scientist and bioinformatic researcher Zheng Wang ispoised to help researchers see every aspect of the genome in super-resolution 3D formalmost an impossibility through the microscopeto better interpret its biological meaning.

Wang, who specializes in bioinformatics research, an interdisciplinaryfield combining biology, statistics, and computer science, recently received a five-year, $1.82 million Maximizing Investigators' Research Award (MIRA), considered one of the most prestigious National Institutes of Health grants for outstanding investigators, to develop more complex computational algorithms that will enable closer looks at the 3D genome.

"This is very exciting news, said Wang. This award will help me develop a new 3D perspective for studying the genome. Over the next five years, I hope to develop computational algorithms toreconstruct the 3D genome structures of single cells and builddeep-learning algorithms toenhance the resolution of whats known as Hi-C, the biochemistry experiment for detecting spatial proximity between different parts of the genome.

Although Wang is the sole principal investigator of the award, he said he cannot do his work without collaborators. He already has enlisted the help of Miller School of Medicine neuroscientists Vance Lemmon and John Bixby. Their lab is providing samples of mouse genomes to help Wang examine the changes of the 3D genome structures during the regenerative process of damaged neuron cells.

The scientist is also using Hi-C data generated by other biochemistry labs that use human brain, liver, spleen, stomach, and cancer cells. Neither a computer program nor the Hi-C experiment can directly detect the 3D genome structure. But a biochemical wet lab can provide the cells, or Hi-C data, that will enable me to create the intelligent algorithms to build the 3D genome structures and then analyze them very, very closely, Wang explained.

The award also will help Wang answer scientific questions on how the structure of the genome influences gene regulation and other important biological processes of the cells, as well as the role of the long non-coding RNAs in the formation of genome structures.

The scientific question that fascinates me is why the 3D genomestructures are different and what consequences these differences will lead to, said Wang. With this award, I hope to answer fundamental and biological questions that can then be used when studying the genome. One of my goals is to help other scientists develop further research so that they can go deeper into the genome and be able to study specific diseases.

Follow this link:
Scientist takes a closer look at the genome - University of Miami

Biochemistry

Postdoctoral studies on the molecular mechanisms that regulate aging – Nature.com

September 18, 2020 medical

The Department of Biosciences and Nutrition performs research and education in several areas of medical science including aging, molecular endocrinology, cancer biology, functional genomics, systems biology, epigenetics, structural biochemistry, bioorganic chemistry, cellular virology, and nutrition. It offers an excellent international research and working environment, including around 250 scientists, students, administrative and technical personnel. The Department resides in the new biomedical research building Neo, aimed at being a creative and open environment that enables meetings, synergies, and exploration of areas of mutual interest across disciplines.

Do you want to contribute to top quality medical research?

Aging is one of the main risk factors for morbidity and mortality. Thus, a better understanding of the mechanisms that regulate this process is highly desirable. One of our efforts focuses on arguably the most important aging regulator known to date, the transcription factor DAF-16/FOXO. It resides downstream of the nutrient-sensing insulin/IGF signaling pathway and in response to low nutrients activates gene expression programs that slow down the aging process. DAF-16/FOXO depends on a diverse range of binding partners and regulators to fulfill its role, and we are studying their functions by diverse biochemical, genetic, and cytological techniques. (See Lin et al., Nature Communications 2018, or Sen et al., Nature Communications 2020, for examples of such work from our lab.)

Your mission

We are looking for a Postdoc to join our research group, the lab of Christian Riedel. Focus of this position is to explore a new binding partner of DAF-16/FOXO which we found to be required for DAF-16/FOXO to promote longevity in response to low nutrient signals. This work is conducted both in the model organism C. elegans and in human cells. You will synergize with aging biologists and bioinformaticians from the Riedel lab and be part of a larger aging-focused research environment at our department, which also contains the labs of Martin Berg and Maria Eriksson.

We are looking for a talented and highly motivated scientist with a doctoral degree and strong background in Molecular Biology, Cell Biology, Genetics, and/or Biochemistry. Good expertise in either C. elegans methods or in mammalian cell culture techniques is desired. Also, a background in the biology of aging is appreciated, even though it is not essential.

Applicants are expected to work independently but as part of an enthusiastic team and to be proficient in English. They are expected to play a leading role in the design and execution of their experiments as well as the analysis and the presentation/publication of the resulting data. Before and while being in the lab, the applicant will be encouraged to apply for competitive national and international postdoctoral fellowships and career grants and will receive support in those endeavors.

This position will be financed by a postdoc scholarship paid out by Karolinska Institutet.

Scholarships for postdoctoral qualification can be established for foreign researchers who place their qualifications in Sweden. The purpose of scholarships for postdoctoral qualification is to promote internationalization and contribute to research qualification after a doctorate or equivalent.A scholarship for carrying out postdoctoral research can be granted for a maximum of two years within a four year period following the receipt of a doctoral degree or equivalent.To be eligible for a postdoctoral scholarship, the person must have obtained a doctorate or a foreign degree deemed to be equivalent to a doctorate. Applicants who have not completed a doctorate at the end of the application period may also apply, provided that all requirements for a completed degree are met before the (intended) start date of the post doctoral education.

The head of the department determines whether their previous training and scholarly qualifications correspond to a Swedish doctorate or higher.

What do we offer?

A creative and inspiring environment full of expertise and curiosity. Karolinska Institutet is one of the worlds leading medical universities. Our vision is to pursue the development of knowledge about life and to promote a better health for all. At Karolinska Institutet, we conduct successful medical research and hold the largest range of medical education in Sweden.

Location: Department of Biosciences and Nutrition, Neo Building, Flemingsberg

Links: https://ki.se/en/bionut/department-of-biosciences-and-nutrition https://ki.se/en/bionut/christian-riedel-group http://riedellab.org/

The amount is tax free and it is set for twelve months at a time, paid out on a six months basis. In exceptional cases, shorter periods may be acceptable.

An application must contain the following documents in English:

You are welcome to apply at the latest by 16 October 2020.

The application has to be submitted through the Varbi recruitment system.

Originally posted here:
Postdoctoral studies on the molecular mechanisms that regulate aging - Nature.com

Biochemistry

UK research getting to bottom of COVID clots – ABC 36 News – WTVQ

September 18, 2020 medical

The research led by Jeremy Wood, Zach Porterfield and Jamie Sturgill in the Department of Internal Medicine; Beth Garvy in Microbiology, Immunology & Molecular Genetics; and Wally Whiteheart in Molecular & Cellular Biochemistry, suggests localized inflammation in the lungs caused by COVID-19 may be responsible for the increased presence of blood clots in patients.

The study also provides evidence suggesting the risk of thrombosis could persist after the infection clears.

The study examined the blood of 30 COVID-19 patients including 15 who were inpatients in the intensive care unit, and 15 who received care as outpatients at UKs Infectious Diseases Clinic, along with eight disease-free volunteers who acted as a control group.

Compared to baseline, the COVID-19 patients had elevated levels of tissue factor, a protein found in blood that initiates the clotting process. Patients also had reduced levels of protein S, an anticoagulant that helps prevent blood clotting.

The researchers concluded that lung inflammation caused by COVID-19 is what leads to a decrease in protein S. Thisinflammation also causes immune and possible endothelial cell activation, which leads to increased tissue factor protein.

What weve learned is that the clotting is not caused by anything systemic. Localized inflammation in the lungs is whats driving this whole process, Wood said. With an increase in tissue factor and a deficiency in protein S, COVID-19 patients get more blood clotting without the ability to shut it down or control it.

The study additionally showed that protein S levels remained low in some patients even after they tested negative for COVID-19, which suggests that blood clotting issues may persist after infection and long-term monitoring of thrombotic risk may be necessary.

Wood says this preliminary data could be a cause for concern. Certain viruses like HIV are linked to a long-term deficiency in protein S, which causes an ongoing risk of thrombosis in patients. It is not yet known if COVID-19 could cause a similar persisting protein S deficiency.

Tissue factor and protein S are good markers to monitor for long-term thrombosis risk and the data suggest that we need to be monitoring these patients because were not seeing these parameters corrected immediately, Wood said.

The research team recently received a grant from UKsCenter for Clinical and Translational Science(CCTS) to begin a longitudinal study to look at these levels in patients over the next year.

This will help answer the question: will this risk remain like it is in the HIV patients or will it go away?

The study was funded in part by anAlliance Grantthrough the College of Medicine as well as UKsCOVID-19 Unified Research Experts (CURE) Alliancethroughthe Vice President for Research and the College of Medicine and the CCTS. It was a product of collaboration between a number of different groups at UK that have been studying COVID-19.

Additional collaborators includeMartha Sim, Meenakshi Banerjee and Hammodah Alfar in the Department of Molecular and Cellular Biochemistry; Melissa Hollifield and Jerry Woodward with Microbiology, Immunology and Molecular Genetics; Xian Li with the Saha Cardiovascular Research Center; Alice Thornton with the Division of Infectious Disease; and Gail Sievert, Marietta Barton-Baxter and Kenneth Campbell with CCTS.

Visit link:
UK research getting to bottom of COVID clots - ABC 36 News - WTVQ

Biochemistry

Global Blood Cell Analyzer Industry – Yahoo Finance

September 18, 2020 medical

Global Blood Cell Analyzer Market to Reach $2. 1 Billion by 2027. Amid the COVID-19 crisis, the global market for Blood Cell Analyzer estimated at US$1. 5 Billion in the year 2020, is projected to reach a revised size of US$2.

New York, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Blood Cell Analyzer Industry" - https://www.reportlinker.com/p05960820/?utm_source=GNW 1 Billion by 2027, growing at aCAGR of 4.8% over the period 2020-2027. Semi-automated Biochemistry Analyzers, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$539.5 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Fully Automated Biochemistry Analyzers segment is readjusted to a revised 4.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $439.7 Million, While China is Forecast to Grow at 4.5% CAGR

The Blood Cell Analyzer market in the U.S. is estimated at US$439.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$366.3 Million by the year 2027 trailing a CAGR of 4.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 3.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.We bring years of research experience to this 8th edition of our report. The 277-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

Read the full report: https://www.reportlinker.com/p05960820/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW Global Competitor Market Shares Blood Cell Analyzer Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Blood Cell Analyzer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 2: World Historic Review for Blood Cell Analyzer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 3: World 15-Year Perspective for Blood Cell Analyzer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Semi-automated Biochemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 5: World Historic Review for Semi-automated Biochemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 6: World 15-Year Perspective for Semi-automated Biochemistry Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Fully Automated Biochemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 8: World Historic Review for Fully Automated Biochemistry Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 9: World 15-Year Perspective for Fully Automated Biochemistry Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Bench-top by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 11: World Historic Review for Bench-top by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 12: World 15-Year Perspective for Bench-top by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Floor-standing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 14: World Historic Review for Floor-standing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 15: World 15-Year Perspective for Floor-standing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 17: World Historic Review for Clinical Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 18: World 15-Year Perspective for Clinical Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Drug development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 20: World Historic Review for Drug development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 21: World 15-Year Perspective for Drug development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 26: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 27: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 29: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 30: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 32: World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 33: World 15-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 34: World Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 35: World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 36: World 15-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 37: World Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 38: World Historic Review for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 39: World 15-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

Table 40: World Current & Future Analysis for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027

Table 41: World Historic Review for Academic Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 42: World 15-Year Perspective for Academic Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES Market Facts & Figures US Blood Cell Analyzer Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 43: USA Current & Future Analysis for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 44: USA Historic Review for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 45: USA 15-Year Perspective for Blood Cell Analyzer by Product Type - Percentage Breakdown of Value Sales for Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers for the Years 2012, 2020 & 2027

Table 46: USA Current & Future Analysis for Blood Cell Analyzer by Modality - Bench-top and Floor-standing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 47: USA Historic Review for Blood Cell Analyzer by Modality - Bench-top and Floor-standing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 48: USA 15-Year Perspective for Blood Cell Analyzer by Modality - Percentage Breakdown of Value Sales for Bench-top and Floor-standing for the Years 2012, 2020 & 2027

Table 49: USA Current & Future Analysis for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 50: USA Historic Review for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 51: USA 15-Year Perspective for Blood Cell Analyzer by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug development and Other Applications for the Years 2012, 2020 & 2027

Table 52: USA Current & Future Analysis for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 53: USA Historic Review for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 54: USA 15-Year Perspective for Blood Cell Analyzer by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2020 & 2027

CANADA Table 55: Canada Current & Future Analysis for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 56: Canada Historic Review for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 57: Canada 15-Year Perspective for Blood Cell Analyzer by Product Type - Percentage Breakdown of Value Sales for Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers for the Years 2012, 2020 & 2027

Table 58: Canada Current & Future Analysis for Blood Cell Analyzer by Modality - Bench-top and Floor-standing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 59: Canada Historic Review for Blood Cell Analyzer by Modality - Bench-top and Floor-standing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 60: Canada 15-Year Perspective for Blood Cell Analyzer by Modality - Percentage Breakdown of Value Sales for Bench-top and Floor-standing for the Years 2012, 2020 & 2027

Table 61: Canada Current & Future Analysis for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 62: Canada Historic Review for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 63: Canada 15-Year Perspective for Blood Cell Analyzer by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug development and Other Applications for the Years 2012, 2020 & 2027

Table 64: Canada Current & Future Analysis for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 65: Canada Historic Review for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 66: Canada 15-Year Perspective for Blood Cell Analyzer by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2020 & 2027

JAPAN Table 67: Japan Current & Future Analysis for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 68: Japan Historic Review for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 69: Japan 15-Year Perspective for Blood Cell Analyzer by Product Type - Percentage Breakdown of Value Sales for Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers for the Years 2012, 2020 & 2027

Table 70: Japan Current & Future Analysis for Blood Cell Analyzer by Modality - Bench-top and Floor-standing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 71: Japan Historic Review for Blood Cell Analyzer by Modality - Bench-top and Floor-standing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 72: Japan 15-Year Perspective for Blood Cell Analyzer by Modality - Percentage Breakdown of Value Sales for Bench-top and Floor-standing for the Years 2012, 2020 & 2027

Table 73: Japan Current & Future Analysis for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 74: Japan Historic Review for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 75: Japan 15-Year Perspective for Blood Cell Analyzer by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug development and Other Applications for the Years 2012, 2020 & 2027

Table 76: Japan Current & Future Analysis for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 77: Japan Historic Review for Blood Cell Analyzer by End-Use - Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 78: Japan 15-Year Perspective for Blood Cell Analyzer by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations and Academic Research Institutes for the Years 2012, 2020 & 2027

CHINA Table 79: China Current & Future Analysis for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 80: China Historic Review for Blood Cell Analyzer by Product Type - Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 81: China 15-Year Perspective for Blood Cell Analyzer by Product Type - Percentage Breakdown of Value Sales for Semi-automated Biochemistry Analyzers and Fully Automated Biochemistry Analyzers for the Years 2012, 2020 & 2027

Table 82: China Current & Future Analysis for Blood Cell Analyzer by Modality - Bench-top and Floor-standing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 83: China Historic Review for Blood Cell Analyzer by Modality - Bench-top and Floor-standing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 84: China 15-Year Perspective for Blood Cell Analyzer by Modality - Percentage Breakdown of Value Sales for Bench-top and Floor-standing for the Years 2012, 2020 & 2027

Table 85: China Current & Future Analysis for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027

Table 86: China Historic Review for Blood Cell Analyzer by Application - Clinical Diagnostics, Drug development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019

Table 87: China 15-Year Perspective for Blood Cell Analyzer by Application - Percentage Breakdown of Value Sales for Clinical Diagnostics, Drug development and Other Applications for the Years 2012, 2020 & 2027

Link:
Global Blood Cell Analyzer Industry - Yahoo Finance